{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:53:19Z","timestamp":1790146399099,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000544","name":"British Association for Psychopharmacology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000544","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jogoh.2020.101713","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T19:55:08Z","timestamp":1582055708000},"page":"101713","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Comparison of HE 4, CA 125, ROMA score and ultrasound score in the differential diagnosis of ovarian masses"],"prefix":"10.1016","volume":"49","author":[{"given":"Koray","family":"Aslan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. An\u0131l","family":"Onan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canan","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neslihan","family":"Bukan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogoh.2020.101713_bib0005","first-page":"10","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jogoh.2020.101713_bib0010","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ogc.2012.02.007","article-title":"Ovarian cancer: screening and early detection","volume":"39","author":"Goff","year":"2012","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.jogoh.2020.101713_bib0015","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/jnci\/djr342","article-title":"Ovarian cancer, five-year stage-specific relative survival rates (2004-2008)","volume":"103","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jogoh.2020.101713_bib0020","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ygyno.2005.07.008","article-title":"Who should operate on patients with ovarian cancer? An evidence-based review","volume":"99","author":"Giede","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogoh.2020.101713_bib0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0090-8258(89)90031-0","article-title":"Macroscopic characterization of ovarian tumors and the relation to the histological diagnosis: criteria to be used for ultrasound evaluation","volume":"35","author":"Granberg","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogoh.2020.101713_bib0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejca.2016.01.007","article-title":"Subjective assessment versus ultrasound models to diagnose ovarian cancer: a systematic review and meta-analysis","volume":"58","author":"Meys","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jogoh.2020.101713_bib0035","first-page":"1535","article-title":"Role of tumour markers in monitoring epithelial ovarian cancer","volume":"82","author":"Meyer","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jogoh.2020.101713_bib0040","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1158\/1940-6207.CAPR-11-0378","article-title":"Personalizing CA125 levels for ovarian cancer screening","volume":"4","author":"Dorigo","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.jogoh.2020.101713_bib0045","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/modpathol.3800612","article-title":"Comprehensive analysis of HE4 expression in normal and malignant human tissues","volume":"19","author":"Galgano","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jogoh.2020.101713_bib0050","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/sj.bjc.6605011","article-title":"Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts","volume":"100","author":"Huhtinen","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jogoh.2020.101713_bib0055","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogoh.2020.101713_bib0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cca.2014.11.013","article-title":"Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses","volume":"440","author":"Chen","year":"2015","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jogoh.2020.101713_bib0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s007950300002","article-title":"Histological classification of ovarian cancer","volume":"36","author":"Kaku","year":"2003","journal-title":"Med Electron Microsc"},{"key":"10.1016\/j.jogoh.2020.101713_bib0070","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3802\/jgo.2015.26.2.87","article-title":"FIGO Committee on Gynecologic Oncology FC on G. FIGO\u2019s staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication","volume":"26","author":"Prat","year":"2015","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.jogoh.2020.101713_bib0075","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1471-0528.1990.tb02448.x","article-title":"A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer","volume":"97","author":"Jacobs","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jogoh.2020.101713_bib0080","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.jogoh.2020.101713_bib0085","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/sj.bjc.6606092","article-title":"HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm","volume":"104","author":"Van Gorp","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jogoh.2020.101713_bib0090","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3802\/jgo.2011.22.4.244","article-title":"Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass","volume":"22","author":"Partheen","year":"2011","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.jogoh.2020.101713_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1746-1596-8-11","article-title":"Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response","volume":"8","author":"Hamed","year":"2013","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.jogoh.2020.101713_bib0100","first-page":"1087","article-title":"HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases","volume":"32","author":"Molina","year":"2011","journal-title":"J Immunother Emphasis Tumor Immunol"},{"key":"10.1016\/j.jogoh.2020.101713_bib0105","first-page":"111","article-title":"HE4 and mesothelin: novel biomarkers of ovarian carcinoma in patients with pelvic masses","volume":"11","author":"Abdel-Azeez","year":"2010","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.jogoh.2020.101713_bib0110","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/jclinpath-2012-201031","article-title":"Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis : a systematic review","volume":"66","author":"Ferraro","year":"2013","journal-title":"J Clin Patho"},{"key":"10.1016\/j.jogoh.2020.101713_bib0115","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-12-258","article-title":"Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis","volume":"12","author":"Li","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jogoh.2020.101713_bib0120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejca.2016.01.007","article-title":"Subjective assessment versus ultrasound models to diagnose ovarian cancer: a systematic review and meta-analysis","volume":"58","author":"Meys EMJ","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jogoh.2020.101713_bib0125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ygyno.2012.03.048","article-title":"Preoperative identification of a suspicious adnexal mass: a systematic review and meta-analysis","volume":"126","author":"Dodge","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jogoh.2020.101713_bib0130","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijgo.2006.10.006","article-title":"The risk of malignancy index in discrimination of adnexal masses","volume":"96","author":"Ulusoy","year":"2007","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.jogoh.2020.101713_bib0135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13048-017-0351-2","article-title":"A prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass","volume":"10","author":"Dora","year":"2017","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.jogoh.2020.101713_bib0140","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1158\/1940-6207.CAPR-11-0378","article-title":"Personalizing CA125 levels for ovarian Cancer screening","volume":"4","author":"Dorigo","year":"2011","journal-title":"Cancer Prev Res"}],"container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246878472030043X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246878472030043X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T19:52:09Z","timestamp":1776282729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246878472030043X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S246878472030043X"],"URL":"https:\/\/doi.org\/10.1016\/j.jogoh.2020.101713","relation":{},"ISSN":["2468-7847"],"issn-type":[{"value":"2468-7847","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of HE 4, CA 125, ROMA score and ultrasound score in the differential diagnosis of ovarian masses","name":"articletitle","label":"Article Title"},{"value":"Journal of Gynecology Obstetrics and Human Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogoh.2020.101713","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101713"}}